GDUFA’s second iteration emerges from backlogs and negotiations, promising speed, clarity and transparency
What leading companies are doing to drive holistic improvements across their complex supply chains
North America and Europe will dominate the global biosimilars market as demand rises for these products
There are a number of points of view and opinions on how good or necessary biosimilars actually are
White Papers: In Depth Research
Posted: Feb 08, 2017
As pharma companies look more and more to biologics for their next potential blockbusters, they must face the challenges surrounding these products' scientific complexity and sophisticated development.